South America Biosimilars Market Size, by Country (2024–2032)

The South America Biosimilars Market progressed steadily from *** onward, led by Brazil, which remained the region’s largest and fastest-expanding market. Brazil was valued at USD *** million in *** and is projected to reach USD ***.*** million by ***, driven by enhanced biologics accessibility, supportive regulatory pathways, and broader adoption across oncology and chronic care. Argentina and Chile also showed consistent upward movement in *** and are projected to reach USD *** million and USD *** million, respectively by ***, supported by expanding reimbursement channels and rising healthcare modernization. Colombia recorded steady gains in *** and is projected to increase to USD *** million by ***, while the Rest of South America reflects steady uptake as affordability, biosimilar awareness, and clinical availability continue to expand.